Effect of Ranibizumab and Scatter Laser Photocoagulation or Ranibizumab Alone in Patients with Retinal Vein Occlusion: The RELATE Trial

Trial Profile

Effect of Ranibizumab and Scatter Laser Photocoagulation or Ranibizumab Alone in Patients with Retinal Vein Occlusion: The RELATE Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Ranibizumab (Primary)
  • Indications Branch retinal vein occlusion; Central retinal vein occlusion; Retinal oedema
  • Focus Therapeutic Use
  • Acronyms RELATE
  • Sponsors Genentech
  • Most Recent Events

    • 13 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top